Action Steps for FDA Diversity Action Plans

In this webinar, industry experts offered examples of how diversity action plans vary among therapeutic areas — and why one size does not fit all. They also explained why it’s important to incorporate action plans earlier in the clinical trial process, as well as consequences for failing to follow a submitted plan.

From Conflict to Collaboration: Enhancing Site and Sponsor/CRO Relationships

This webinar explored the perspectives and occasional conflicting interests of both parties, fostering mutual understanding. Representatives from each organization shared insights, real-life examples, and practical tools to overcome challenges, promoted productive collaboration, and contributed to clinical trial success

Deepening Diversity: LGBTQIA+ Diversity in Clinical Research

In this webinar, expert panelists discussed how sponsors can smooth the LGBTQIA+ patient journey for clinical trials, starting with gender-neutral protocols, making trial communication more inclusive, the FDA’s draft guidance on diversity plans and data collection, and the roles that sites/investigators can play.

How Do IRBs Review Virtual Trial Technology?

How will institutional review boards (IRBs) review study protocols involving the ever-increasing array of mobile health (mHealth) technologies and virtual trial apps on the market? This webinar helps clinical research professionals to understand the regulations and how the oversight of virtual trials might differ from what they have traditionally been used to.